Adma Biologics (ADMA) Notes Payables (2011 - 2017)
Adma Biologics (ADMA) recorded Notes Payables of $6.67 million in Q2 2017, unchanged from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Notes Payables (2011 - 2017) Analysis & Trends
At the end of FY2016, Adma Biologics reported Notes Payables of $6.11 million.
- Annual Notes Payables has a five-year compound annual growth rate of 68.5% (FY2011 to FY2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | 6.67 Mn |
| Mar 31, 2017 | 6.67 Mn |
| Dec 31, 2016 | 6.11 Mn |
| Dec 31, 2011 | 450,000.00 |
API Access
Adma Biologics Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();